See also this year's filing and all EDGAR filings for this company.
PDF Report 0000315545_2023_PROVECTUS_BIOPHARMACEUTICALS_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000315545, PROVECTUS BIOPHARMACEUTICALS INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,899,182 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 20,941 |
| 3 | remainder_Assets | 117,123 |
| 4 | LiabilitiesCurrent | 8,192,380 |
| 5 | LiabilitiesNoncurrent | 73,376 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 2,027,628 |
| 9 | ResearchAndDevelopmentExpense | 2,389,360 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 989,042 |
| 12 | remainder_NetIncome | -126,737 |
| 13 | remainder_ComprehensiveNetIncome | -1,212 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,037,246 |
| 1 | Liabilities | 8,265,756 |
| 2 | Expenses | 4,416,988 |
| 3 | Revenues | 989,042 |
| 4 | StockholdersEquity | -6,228,510 |
| 5 | NetIncome | -3,554,683 |
| 6 | ComprehensiveNetIncome | -3,555,289 |
| 7 | BaseVar | 7,918,490 |
| 8 | EconomicCapitalRatio | -2.77 |
Edgar->Model Mapping
Feature Distribution
Change over Time
